People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

New and innovative mechanisms of action are constantly being discovered and developed into medicines that tackle a broad ...

Early and locally advanced breast cancer: diagnosis and management - Neoadjuvant chemotherapy and ovarian function suppression (update) Draft guidance consultation NICE guideline 24 February 2025 ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280] Technology appraisal guidance 5 March 2025 Abaloparatide for treating idiopathic ...

Mental wellbeing is about life satisfaction, optimism, self-esteem, feeling in control, having a purpose and a sense of belonging and support. Older people, including those living in care homes, often ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

All NICE products on COVID-19. Includes any guidance and advice.

the NHS patient and carer organisations academia pharmaceuticals and medical device industries. Although the committee seeks the views of organisations representing health professionals, patients, ...